研究领域
注重冠心病的临床及介入治疗,对高血压、高血脂、心力衰竭及疑难危重症的诊断和治疗经验丰富。
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Clin Appl Thromb Hemost. 2018 Jan 1: 1076029618761005.
2. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Arq Bras Cardiol. 2018 Mar 12;110(4):333-338.
3. The relationship between post-procedural platelet count and left ventricular aneurysm in patients with acute anterior ST-segment elevation myocardial infarction following primary percutaneous coronary intervention. Kardiol Pol. 2018;76(5):899-907.
4. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Kardiol Pol. 2016;74(10):1160-1166.
5. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2016 Apr;71(2):241-6.
6. Altered Therapeutic Window of Coronary Heart Disease Treatment Drug Clopidogrel in Drug-Induced Cholestasis Patients. Lat. Am. J. Pharm. 2016;35(5A):1269-72.
7. Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction. Exp Ther Med. 2016 Dec;12(6):4147-4153.
8. Risk factors for carotid artery stenosis in chinese patients undergoing coronary artery bypass graft interventions. Medcine 94(28) e1119.
学术兼职
第九、十、十一届北京市青年联合会委员
第四届中央国家机关青年联合会委员
第四届中国青年科技工作者协会生物与医药专业委员会委员
中华医学会心血管病分会介入心脏病学组委员
北京医学会内科学分会委员
中国医师协会基层工作委员会常务委员
中国医学救援协会心血管急救分会委员
世界中医药学会联合会介入心脏病专业委员会常务理事
中青年冠脉专家沙龙常务理事兼秘书长
美国SCAI学会国际委员